ATP1A3 (C-terminal) Polyklonaler Antikörper

ATP1A3 (C-terminal) Polyklonal Antikörper für WB, IHC, IF-P, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF-P, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 10868-1-PBS

Synonyme

ATP1A3, ATP1A3 (middle), Alpha(III), ATP1A 3, DYT12



Geprüfte Anwendungen

Produktinformation

10868-1-PBS bindet in WB, IHC, IF-P, Indirect ELISA ATP1A3 (C-terminal) und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen ATP1A3 (C-terminal) fusion protein Ag1313
Vollständiger Name ATPase, Na+/K+ transporting, alpha 3 polypeptide
Berechnetes Molekulargewicht 113 kDa
Beobachtetes Molekulargewicht 100-113 kDa
GenBank-ZugangsnummerBC015566
Gene symbol ATP1A3
Gene ID (NCBI) 478
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ATP1A3 participates in the catalyticing hydrolysis of ATP and the exchanging of sodium and potassium ions across plasma membrane. The catalyticing activity mode is ATP + H2O + Na+(In) + K+(Out) = ADP + phosphate + Na+(Out) + K+(In). It has been published that the neurologic disorders rapid-onset dystonia-parkionsonism (RDP), alternating hemiplegia of childhood (ACH) and CAPOS syndrome (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) are all related with the mutation of ATP1A3. There are other reports suggest that early life epilepsy and episodic apnea revealing are potentially associated with the mutation of ATP1A3 as a result of impairment of Na+/K+ homeostasis. This antibody is generated against the C-terminal region (665-1013aa) of ATP1A3 and detects the band around 100-113 kDa in SDS-PAGE.(PMID: 30097153, 20301294, 29922587)